Subphenotypes in acute respiratory distress syndrome: Latent class analysis of data from two randomised controlled trials

The Lancet Respiratory Medicine

Volumn 2, Issue 8, 2014, Pages 611-620

  Calfee, Carolyn S ^a   Delucchi, Kevin ^b   Parsons, Polly E ^c   Thompson, B Taylor ^d   Ware, Lorraine B ^e   Matthay, Michael A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; BIOLOGICAL MARKER; HYPERTENSIVE AGENT; AUTACOID; VASOCONSTRICTOR AGENT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BICARBONATE BLOOD LEVEL; COHORT ANALYSIS; DATA ANALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HUMAN; INFLAMMATION; LATENT CLASS ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; MORTALITY; ORGAN FAILURE FREE DAY; PHENOTYPE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPSIS; SHOCK; STATISTICAL ANALYSIS; STATISTICAL MODEL; VENTILATOR FREE DAY; AGED; APACHE; ARTIFICIAL VENTILATION; BLOOD; CLASSIFICATION; CONTROLLED STUDY; MIDDLE AGED; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

ADULT; AGED; APACHE; BICARBONATES; BIOMARKERS; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PHENOTYPE; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; TIME FACTORS; VASOCONSTRICTOR AGENTS;

EID: 84905502770     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(14)70097-9     Document Type: Article

References (41)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE Acute respiratory distress in adults. Lancet 1967, 2:319-323.
2. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824.
3. Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012, 307:2526-2533.
4. Calfee CS, Eisner MD, Ware LB, et al. Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit Care Med 2007, 35:2243-2250.
5. Tejera P, Meyer NJ, Chen F, et al. Distinct and replicable genetic risk factors for acute respiratory distress syndrome of pulmonary or extrapulmonary origin. J Med Genet 2012, 49:671-680.
6. Frank AJ, Thompson BT Pharmacological treatments for acute respiratory distress syndrome. Curr Opin Crit Care 2010, 16:62-68.
7. Wenzel SE Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012, 18:716-725.
8. Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med 2011, 365:1088-1098.
9. Wong HR, Cvijanovich NZ, Allen GL, et al. Validation of a gene expression-based subclassification strategy for pediatric septic shock. Crit Care Med 2011, 39:2511-2517.
10. Iskander KN, Osuchowski MF, Stearns-Kurosawa DJ, et al. Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev 2013, 93:1247-1288.
11. McLachlan G, Peel D Finite mixture models 2000, John Wiley & Sons, New York.
12. Ezzedine K, Le Thuaut A, Jouary T, Ballanger F, Taieb A, Bastuji-Garin S Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes. Pigment Cell Melanoma Res 2014, 27:134-139.
13. Rindskopf R, Rindskopf W The value of latent class analysis in medical diagnosis. Stat Med 1986, 5:21-27.
14. Depner M, Fuchs O, Genuneit J, et al. Clinical and epidemiologic phenotypes of childhood asthma. Am J Respir Crit Care Med 2014, 189:129-138.
15. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342:1301-1308. The Acute Respiratory Distress Syndrome.
16. Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2000, 283:1995-2002. The Acute Respiratory Distress Syndrome.
17. Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome. Crit Care Med 2002, 30:1-6. The Acute Respiratory Distress Syndrome.
18. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004, 351:327-336. The Acute Respiratory Distress Syndrome.
19. Ware LB, Eisner MD, Thompson BT, Parsons PE, Matthay MA Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med 2004, 170:766-772.
20. Ware LB, Matthay MA, Parsons PE, Thompson BT, Januzzi JL, Eisner MD Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 2007, 35:1821-1828.
21. Parsons PE, Eisner MD, Thompson BT, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005, 33:1-6.
22. Parsons PE, Matthay MA, Ware LB, Eisner MD Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2005, 288:L426-L431.
23. Eisner MD, Parsons P, Matthay MA, Ware L, Greene K Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 2003, 58:983-988.
24. Calfee CS, Eisner MD, Parsons PE, et al. Soluble intercellular adhesion molecule-1 (sICAM-1) and clinical outcomes in patients with acute lung injury. Intensive Care Med 2008, 35:248-257.
25. Ware LB, Koyama T, Billheimer DD, et al. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 2010, 137:288-296.
26. Lanza ST, Tan X, Bray BC Latent class analysis with distal outcomes: a flexible model-based approach. Struct Equ Modeling 2013, 20:1-26.
27. Shah RJ, Diamond JM, Cantu E, et al. Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation. Chest 2013, 144:616-622.
28. Reilly JP, Bellamy S, Shashaty MG, et al. Heterogeneous phenotypes of the acute respiratory distress syndrome after major trauma. Ann Am Thorac Soc 2014, published online Apr 8. 10.1513/AnnalsATS.201308-280OC.
29. Briel M, Meade M, Mercat A, et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 2010, 303:865-873.
30. Rubenfeld GD How much peep in acute lung injury. JAMA 2010, 303:883-884.
31. Calfee CS, Gallagher D, Abbott J, Thompson BT, Matthay MA Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance. Crit Care Med 2012, 40:1731-1737.
32. Agrawal A, Matthay MA, Kangelaris KN, et al. Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients. Am J Respir Crit Care Med 2013, 187:736-742.
33. Meyer NJ, Li M, Feng R, et al. ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. Am J Respir Crit Care Med 2011, 183:1344-1353.
34. Calfee CS, Ware LB, Eisner MD, et al. Plasma receptor for advanced end-products and clinical outcomes in acute lung injury. Thorax 2008, 63:1083-1089.
35. Kropski JA, Fremont RD, Calfee CS, Ware LB Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury. Chest 2009, 135:1440-1447.
36. Fremont RD, Koyama T, Calfee CS, et al. Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis. J Trauma 2010, 68:1121-1127.
37. Meyer NJ, Feng R, Li M, et al. IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist. Am J Respir Crit Care Med 2013, 187:950-959.
38. Moss M, Bucher B, Moore FA, Moore EE, Parsons PE The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA 1996, 275:50-54.
39. Calfee CS, Matthay MA, Eisner MD, et al. Active and passive cigarette smoking and acute lung injury after severe blunt trauma. Am J Respir Crit Care Med 2011, 183:1660-1665.
40. Thille AW, Esteban A, Fernandez-Segoviano P, et al. Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy. Am J Respir Crit Care Med 2013, 187:761-767.
41. Thille AW, Esteban A, Fernandez-Segoviano P, et al. Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsies. Lancet Respir Med 2013, 1:395-401.